Raising the Bar for Antineoplastic Agents: How to Choose Threshold Values for Superiority Trials in Advanced Solid TumorsAlberto F. Sobrero, Paolo Bruzzi, Alessandro Pastorino et al.|Clinical Cancer Research|2014Cited by 31
Total Neoadjuvant Therapy for Locally Advanced Rectal CancerAlessandro Audisio, Francesco Fiorica, Chiara Gallio et al.|JAMA Oncology|2025Cited by 24
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trialGerardo Rosati, Giordano Beretta, Sara Lonardi et al.|European Journal of Cancer|2021Cited by 15
ctDNA to Guide Treatment of Colorectal Cancer: Ready for Standard of Care?Alberto Puccini, Alberto F. Sobrero, Valentino Martelli et al.|Current Treatment Options in Oncology|2023Cited by 12
You're Cured Till You're Not: Should Disease-Free Survival Be Used as a Regulatory or Clinical End Point for Adjuvant Therapy of Cancer?Alberto F. Sobrero, John Zalcberg, Alessandro Pastorino|Journal of Clinical Oncology|2022Cited by 11